Centre Hospitalier Universitaire Angers
Angers 49933
3 studies enrolling now · 7 studies all time
What they study most
Atrial Fibrillation, Contrast Enhancement in Magnetic Resonance Imaging, Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), Lymphoma, Non-Hodgkin, Multiple Myeloma, Non-central Nervous System Pathology, Prevention of Stroke or Systemic Embolism, Sepsis-Induced Hypotension
Studies at this site
- A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma — Recruiting now
- A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments — Recruiting now
- A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma — Recruiting now
- A Study of REGN7544 for the Treatment in Adult Patients With Sepsis-Induced Hypotension — Completed
- A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems) — Completed
- Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL) — Stopped early
- A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early